Resistance to Ciprofloxacin in urinary infections in patients hospitalized in the medicinainterna service

Urinary tract infections (UTI) are considered as one of the most frequent infectious processes worldwide, representing a high prevalence in the field of public health, due to the statistical increase of healthy people and people with comorbidity who suffer from it, especially due to potential complications such as kidney injury, urinary sepsis, microbial resistance ̧ among others, which directly affect the healthy lifestyle of patients, producing a high cost and impact on health services. The estimated incidence of UTI in our country is currently unknown. However, it is believed that this phenomenon is repeated in other developing countries.1 UTIs represent more than 100,000 hospitalizations per year in countries such as the United States, most of them due to complicated UTIs. Likewise, they represent approximately 40% of all nosocomial infections, which in most cases, are associated with placement of bladder catheters.1,2